https://cloudbreakpharma.com/cloudbreak-receives-u-s-food-and-drug-administration-clearance-to-proceed-with-clinical-study-using-investigational-new-drug-cbt-004/ 2021-03-04T22:35:40+00:00 https://cloudbreakpharma.com/wp-content/uploads/2021/02/iStock-1022809006-min.jpg https://cloudbreakpharma.com/zh_hk/cloudbreak-receives-u-s-food-and-drug-administration-clearance-to-proceed-with-clinical-study-using-investigational-new-drug-cbt-004/ 2021-03-04T14:35:40-08:00 https://cloudbreakpharma.com/wp-content/uploads/2021/02/iStock-1022809006-min.jpg https://cloudbreakpharma.com/zh/cloudbreak-receives-u-s-food-and-drug-administration-clearance-to-proceed-with-clinical-study-using-investigational-new-drug-cbt-004/ 2021-03-04T14:35:40-08:00 https://cloudbreakpharma.com/wp-content/uploads/2021/02/iStock-1022809006-min.jpg https://cloudbreakpharma.com/cloudbreak-receives-u-s-food-and-drug-administration-clearance-to-proceed-with-clinical-study-using-investigational-new-drug-cbt-006/ 2021-03-04T22:36:01+00:00 https://cloudbreakpharma.com/wp-content/uploads/2021/02/iStock-1022809006-min.jpg https://cloudbreakpharma.com/zh_hk/cloudbreak-receives-u-s-food-and-drug-administration-clearance-to-proceed-with-clinical-study-using-investigational-new-drug-cbt-006/ 2021-03-04T14:36:01-08:00 https://cloudbreakpharma.com/wp-content/uploads/2021/02/iStock-1022809006-min.jpg https://cloudbreakpharma.com/zh/cloudbreak-receives-u-s-food-and-drug-administration-clearance-to-proceed-with-clinical-study-using-investigational-new-drug-cbt-006/ 2021-03-04T14:36:01-08:00 https://cloudbreakpharma.com/wp-content/uploads/2021/02/iStock-1022809006-min.jpg https://cloudbreakpharma.com/ms-rebecca-chan-a-former-senior-executive-of-the-listing-division-of-the-hong-kong-stock-exchange-and-ex-partners-of-three-out-of-four-big-four-international-firms-joins-cloudbreak-pharma-as-the-ch/ 2022-06-02T07:02:23+00:00 https://cloudbreakpharma.com/wp-content/uploads/2021/03/iStock-924641334-min-scaled.jpg https://cloudbreakpharma.com/wp-content/uploads/2022/06/Rebecca.jpg https://cloudbreakpharma.com/zh_hk/ms-rebecca-chan-a-former-senior-executive-of-the-listing-division-of-the-hong-kong-stock-exchange-and-ex-partners-of-three-out-of-four-big-four-international-firms-joins-cloudbreak-pharma-as-the-ch/ 2022-06-02T00:02:23-07:00 https://cloudbreakpharma.com/wp-content/uploads/2021/03/iStock-924641334-min-scaled.jpg https://cloudbreakpharma.com/wp-content/uploads/2022/06/Rebecca.jpg https://cloudbreakpharma.com/zh/ms-rebecca-chan-a-former-senior-executive-of-the-listing-division-of-the-hong-kong-stock-exchange-and-ex-partners-of-three-out-of-four-big-four-international-firms-joins-cloudbreak-pharma-as-the-ch/ 2022-06-02T00:02:23-07:00 https://cloudbreakpharma.com/wp-content/uploads/2021/03/iStock-924641334-min-scaled.jpg https://cloudbreakpharma.com/wp-content/uploads/2022/06/Rebecca.jpg https://cloudbreakpharma.com/cloudbreak-pharma-joins-ophthalmology-tech-summit-2022/ 2022-06-12T14:04:09+00:00 https://cloudbreakpharma.com/wp-content/uploads/2022/06/OTS-banner.png https://cloudbreakpharma.com/wp-content/uploads/2022/06/OTS-banner.png https://cloudbreakpharma.com/zh_hk/cloudbreak-pharma-joins-ophthalmology-tech-summit-2022/ 2022-06-12T07:04:09-07:00 https://cloudbreakpharma.com/wp-content/uploads/2022/06/OTS-banner.png https://cloudbreakpharma.com/wp-content/uploads/2022/06/OTS-banner.png https://cloudbreakpharma.com/zh/cloudbreak-pharma-joins-ophthalmology-tech-summit-2022/ 2022-06-12T07:04:09-07:00 https://cloudbreakpharma.com/wp-content/uploads/2022/06/OTS-banner.png https://cloudbreakpharma.com/wp-content/uploads/2022/06/OTS-banner.png https://cloudbreakpharma.com/abu-abraham-m-d-s-appointment-as-chief-medical-officer/ 2022-06-26T23:39:00+00:00 https://cloudbreakpharma.com/wp-content/uploads/2022/06/Abu-Abraham-cropped.jpg https://cloudbreakpharma.com/wp-content/uploads/2022/06/Abu-Abraham.jpg https://cloudbreakpharma.com/zh_hk/abu-abraham-m-d-s-appointment-as-chief-medical-officer/ 2022-06-26T16:39:00-07:00 https://cloudbreakpharma.com/wp-content/uploads/2022/06/Abu-Abraham-cropped.jpg https://cloudbreakpharma.com/wp-content/uploads/2022/06/Abu-Abraham.jpg https://cloudbreakpharma.com/zh/abu-abraham-m-d-s-appointment-as-chief-medical-officer/ 2022-06-26T16:39:00-07:00 https://cloudbreakpharma.com/wp-content/uploads/2022/06/Abu-Abraham-cropped.jpg https://cloudbreakpharma.com/wp-content/uploads/2022/06/Abu-Abraham.jpg https://cloudbreakpharma.com/potential-unicorn-for-2023/ 2023-06-28T02:09:04+00:00 https://cloudbreakpharma.com/wp-content/uploads/2023/06/IMG_8455.jpg https://cloudbreakpharma.com/wp-content/uploads/2023/06/IMG_8455.jpg https://cloudbreakpharma.com/zh_hk/potential-unicorn-for-2023/ 2023-06-27T19:09:04-07:00 https://cloudbreakpharma.com/wp-content/uploads/2023/06/IMG_8455.jpg https://cloudbreakpharma.com/wp-content/uploads/2023/06/IMG_8455.jpg https://cloudbreakpharma.com/zh/potential-unicorn-for-2023/ 2023-06-27T19:09:04-07:00 https://cloudbreakpharma.com/wp-content/uploads/2023/06/IMG_8455.jpg https://cloudbreakpharma.com/wp-content/uploads/2023/06/IMG_8455.jpg https://cloudbreakpharma.com/seeing-life-better-through-medicine/ 2023-08-14T05:53:32+00:00 https://cloudbreakpharma.com/wp-content/uploads/2022/08/iStock-1316584899-min.jpg https://cloudbreakpharma.com/zh_hk/通过医学让生活更美好/ 2023-08-13T22:53:32-07:00 https://cloudbreakpharma.com/wp-content/uploads/2022/08/iStock-1316584899-min.jpg https://cloudbreakpharma.com/zh/通过医学让生活更美好/ 2023-08-13T22:53:32-07:00 https://cloudbreakpharma.com/wp-content/uploads/2022/08/iStock-1316584899-min.jpg https://cloudbreakpharma.com/cbt-004-has-completed-the-first-patient-in-for-phase-ii-clinical-trials-in-the-us/ 2024-03-22T04:39:22+00:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg https://cloudbreakpharma.com/zh_hk/cbt-004-has-completed-the-first-patient-in-for-phase-ii-clinical-trials-in-the-us/ 2024-03-21T21:39:22-07:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg https://cloudbreakpharma.com/zh/cbt-004-has-completed-the-first-patient-in-for-phase-ii-clinical-trials-in-the-us/ 2024-03-21T21:39:22-07:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg https://cloudbreakpharma.com/remarkable-progress-in-clinical-trials-cbt-009-and-cbt-004/ 2024-03-22T04:40:54+00:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg https://cloudbreakpharma.com/zh_hk/remarkable-progress-in-clinical-trials-cbt-009-and-cbt-004/ 2024-03-21T21:40:54-07:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg https://cloudbreakpharma.com/zh/remarkable-progress-in-clinical-trials-cbt-009-and-cbt-004/ 2024-03-21T21:40:54-07:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg https://cloudbreakpharma.com/new-drug-cbt-009-approved-to-conduct-phase-i-ii-clinical-trial-in-australia/ 2024-03-22T04:42:27+00:00 https://cloudbreakpharma.com/wp-content/uploads/2021/03/iStock-1203853759-min-scaled.jpg https://cloudbreakpharma.com/zh_hk/new-drug-cbt-009-approved-to-conduct-phase-i-ii-clinical-trial-in-australia/ 2024-03-21T21:42:27-07:00 https://cloudbreakpharma.com/wp-content/uploads/2021/03/iStock-1203853759-min-scaled.jpg https://cloudbreakpharma.com/zh/new-drug-cbt-009-approved-to-conduct-phase-i-ii-clinical-trial-in-australia/ 2024-03-21T21:42:27-07:00 https://cloudbreakpharma.com/wp-content/uploads/2021/03/iStock-1203853759-min-scaled.jpg https://cloudbreakpharma.com/cloudbreak-completed-phase-ii-clinical-trial-for-cbt-006-in-the-u-s-for-the-treatment-of-meibomian-gland-dysfunction-associated-dry-eye-disease/ 2024-03-22T04:44:45+00:00 https://cloudbreakpharma.com/wp-content/uploads/2021/03/iStock-1156669273-min-scaled.jpg https://cloudbreakpharma.com/wp-content/uploads/2022/06/JS-e1656285590986.png https://cloudbreakpharma.com/zh_hk/cloudbreak-completed-phase-ii-clinical-trial-for-cbt-006-in-the-u-s-for-the-treatment-of-meibomian-gland-dysfunction-associated-dry-eye-disease/ 2024-03-21T21:44:45-07:00 https://cloudbreakpharma.com/wp-content/uploads/2021/03/iStock-1156669273-min-scaled.jpg https://cloudbreakpharma.com/wp-content/uploads/2022/06/JS-e1656285590986.png https://cloudbreakpharma.com/zh/cloudbreak-completed-phase-ii-clinical-trial-for-cbt-006-in-the-u-s-for-the-treatment-of-meibomian-gland-dysfunction-associated-dry-eye-disease/ 2024-03-21T21:44:45-07:00 https://cloudbreakpharma.com/wp-content/uploads/2021/03/iStock-1156669273-min-scaled.jpg https://cloudbreakpharma.com/wp-content/uploads/2022/06/JS-e1656285590986.png https://cloudbreakpharma.com/dr-jinsong-ni-awarded-shishan-technology-innovation-and-entrepreneurship-leading-talent-title/ 2024-03-22T04:48:47+00:00 https://cloudbreakpharma.com/wp-content/uploads/2022/06/Jinsong-cropped.png https://cloudbreakpharma.com/wp-content/uploads/2022/06/JS-e1656285590986.png https://cloudbreakpharma.com/zh_hk/dr-jinsong-ni-awarded-shishan-technology-innovation-and-entrepreneurship-leading-talent-title/ 2024-03-21T21:48:47-07:00 https://cloudbreakpharma.com/wp-content/uploads/2022/06/Jinsong-cropped.png https://cloudbreakpharma.com/wp-content/uploads/2022/06/JS-e1656285590986.png https://cloudbreakpharma.com/zh/dr-jinsong-ni-awarded-shishan-technology-innovation-and-entrepreneurship-leading-talent-title/ 2024-03-21T21:48:47-07:00 https://cloudbreakpharma.com/wp-content/uploads/2022/06/Jinsong-cropped.png https://cloudbreakpharma.com/wp-content/uploads/2022/06/JS-e1656285590986.png https://cloudbreakpharma.com/cloudbreak-and-cevr/ 2024-03-22T04:49:45+00:00 https://cloudbreakpharma.com/wp-content/uploads/2023/05/holding-slides-MOU-2.png https://cloudbreakpharma.com/wp-content/uploads/2023/05/%E6%88%AA%E5%B1%8F2023-05-18-%E4%B8%8A%E5%8D%8810.03.03.png https://cloudbreakpharma.com/zh_hk/拨康视云-2/ 2024-03-21T21:49:45-07:00 https://cloudbreakpharma.com/wp-content/uploads/2023/05/holding-slides-MOU-2.png https://cloudbreakpharma.com/wp-content/uploads/2023/05/截屏2023-05-18-上午10.03.03.png https://cloudbreakpharma.com/zh/拨康视云-2/ 2024-03-21T21:49:45-07:00 https://cloudbreakpharma.com/wp-content/uploads/2023/05/holding-slides-MOU-2.png https://cloudbreakpharma.com/wp-content/uploads/2023/05/截屏2023-05-18-上午10.03.03.png https://cloudbreakpharma.com/cloudbreak-a-clinical-stage-company-dedicated-to-improving-vision-health/ 2024-03-22T06:27:11+00:00 https://cloudbreakpharma.com/wp-content/uploads/2023/08/bdb249367c8d1548d4c626151f749d0.jpg https://cloudbreakpharma.com/zh_hk/拨康视云/ 2024-03-21T23:27:11-07:00 https://cloudbreakpharma.com/wp-content/uploads/2023/08/bdb249367c8d1548d4c626151f749d0.jpg https://cloudbreakpharma.com/zh/拨康视云/ 2024-03-21T23:27:11-07:00 https://cloudbreakpharma.com/wp-content/uploads/2023/08/bdb249367c8d1548d4c626151f749d0.jpg https://cloudbreakpharma.com/santen-and-cloudbreak-execute-a-new-licensing-agreement-for-cbt-001-a-topical-treatment-of-pterygium/ 2024-08-06T06:14:21+00:00 https://cloudbreakpharma.com/wp-content/uploads/2024/08/%E5%BE%AE%E4%BF%A1%E6%88%AA%E5%9B%BE_20240806105952.jpg https://cloudbreakpharma.com/zh_hk/santen-and-cloudbreak-execute-a-new-licensing-agreement-for-cbt-001-a-topical-treatment-of-pterygium/ 2024-08-05T23:14:21-07:00 https://cloudbreakpharma.com/wp-content/uploads/2024/08/微信截图_20240806105952.jpg https://cloudbreakpharma.com/zh/santen-and-cloudbreak-execute-a-new-licensing-agreement-for-cbt-001-a-topical-treatment-of-pterygium/ 2024-08-05T23:14:21-07:00 https://cloudbreakpharma.com/wp-content/uploads/2024/08/微信截图_20240806105952.jpg https://cloudbreakpharma.com/cloudbreak-pharma-inc-s-cbt-004-indicated-for-the-treatment-of-vascularised-pinguecula-has-completed-phase-ii-clinical-trials-in-the-united-states/ 2025-05-15T09:08:43+00:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg https://cloudbreakpharma.com/zh_hk/cloudbreak-pharma-inc-s-cbt-004-indicated-for-the-treatment-of-vascularised-pinguecula-has-completed-phase-ii-clinical-trials-in-the-united-states/ 2025-05-15T02:08:43-07:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg https://cloudbreakpharma.com/zh/cloudbreak-pharma-inc-s-cbt-004-indicated-for-the-treatment-of-vascularised-pinguecula-has-completed-phase-ii-clinical-trials-in-the-united-states/ 2025-05-15T02:08:43-07:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg https://cloudbreakpharma.com/cloudbreak-pharmas-global-innovative-ophthalmic-pipeline-cbt-001-completes-the-enrollment-of-all-patients-in-the-international-multi-center-phase-iii-clinical-trial/ 2025-06-04T09:01:33+00:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg https://cloudbreakpharma.com/zh_hk/cloudbreak-pharmas-global-innovative-ophthalmic-pipeline-cbt-001-completes-the-enrollment-of-all-patients-in-the-international-multi-center-phase-iii-clinical-trial/ 2025-06-04T02:01:33-07:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg https://cloudbreakpharma.com/zh/cloudbreak-pharmas-global-innovative-ophthalmic-pipeline-cbt-001-completes-the-enrollment-of-all-patients-in-the-international-multi-center-phase-iii-clinical-trial/ 2025-06-04T02:01:33-07:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg https://cloudbreakpharma.com/news-jan-27-2026/ 2026-01-27T19:40:05+00:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg https://cloudbreakpharma.com/zh_hk/news-jan-27-2026/ 2026-01-27T11:40:05-08:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg https://cloudbreakpharma.com/zh/news-jan-27-2026/ 2026-01-27T11:40:05-08:00 https://cloudbreakpharma.com/wp-content/uploads/2023/10/f406cb5a7d1249474969aa8465fcf43.jpeg